The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

November 30, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Puerarin injection 400 mg

Patients receive treatment with oral anti-rheumatic agents and/or non-steroidal anti-inflammatory drugs, prednisone, aspirin, statins, bone metabolism regulators and gastric mucosal protective agents on as-needed basis.Furthermore, patients were administrated with 400 mg intravenously infused puerarin injection once a day.Each treatment course lasted for 2 weeks followed by a regular time interval of 15 days.

DRUG

Control

Patients receive treatment with oral anti-rheumatic agents and/or non-steroidal anti-inflammatory drugs, prednisone, aspirin, statins, bone metabolism regulators and gastric mucosal protective agents on as-needed basis

All Listed Sponsors
lead

Chengdu PLA General Hospital

OTHER

NCT02254655 - The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter